Fundraising FoxTravus Therapeutics
Winston-Salem, US · Founded 2014 · Delaware corporation
Find your way into Travus Therapeutics
Sign up to see every warm intro you have to Travus Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Travus Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
JD
Jerel DavisBoard director
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2016
▶$750KraisedJul 2016 · 4 investors · BiotechnologyRule 506(b)
▶$750KraisedJul 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John FinnExecutive Officer, Director
- Jerel DavisDirector
- Offering amount
- $2.3M
- Amount sold
- $750K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Travus Therapeutics raised?
- Travus Therapeutics has disclosed $750K raised across 1 round.
- Where is Travus Therapeutics headquartered?
- Travus Therapeutics is headquartered in Winston-Salem, US.